An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, physicians and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to users administering products of unknown origin.
Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or prison.
Service Reaction and Content Removal
Based on the social media company, the platform has removed problematic material and prohibited related keywords and query recommendations. The organization stated it was dedicated to keeping the platform secure and allocating resources in enhancing compliance measures.
Digital Trading Activities
Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at home.
Within minutes of entering one group, a vendor shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.
Item Information and Costs
Within these communities, posts show black plastic packages with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting materials they can’t verify. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.